Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Dr. Löwenmark AB
AB
In liquidation
Org 5590944665
Medical specialists activities
·
NACE 8622
Est. 2016 · 9 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Medical specialists activities
/
Dr. Löwenmark AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
1M
1M
1M
0M
0M
2020: 1M
1M
2020
2021: 1M (0% vs 2020)
1M
0%
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 0M (-100% vs 2022)
0M
-100%
2023
2024: 0M
0M
2024
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
0
355
1 098
994
938
Staff expenses
−0
−103
−704
—
—
EBITDA
−28
166
293
216
340
Depreciation & amort.
—
—
—
−0
−0
EBIT
−28
166
293
216
340
Net financials
1
0
−1
—
−1
Profit before tax
−27
167
292
216
339
Tax
—
−34
−60
−45
−75
Net profit
−27
133
232
171
264
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
62
194
395
403
689
Equity
56
183
282
231
319
Long-term debt
—
—
—
0
0
Short-term debt
6
11
113
172
369
Total debt
6
11
113
172
369
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2020
2024
Equity ratio
90,9 %
This company
38,2 %
Market median
This company
Market median
138% above market
2020
2024
Return on equity
−47,3 %
This company
18,4 %
Market median
This company
Market median
357% below market
2020
2024
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2020
2024
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2020
2024
Debt / equity
0,10×
This company
0,62×
Market median
This company
Market median
84% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Dr. Löwenmark AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
Riskpilot